# Intravenous Tranexamic Acid Reducing Intraoperative Blood Loss in Huge Meningiomas Resection

> **NCT05230381** · NA · UNKNOWN · sponsor: **Beijing Tiantan Hospital** · enrollment: 228 (estimated)

## Conditions studied

- Tranexamic Acid
- Intraoperative Blood Loss
- Meningioma

## Interventions

- **DRUG:** Continous infusion
- **DRUG:** Single infusion
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05230381
- **Lead sponsor:** Beijing Tiantan Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-06-15
- **Primary completion:** 2024-12-30
- **Final completion:** 2025-06-30
- **Target enrollment:** 228 (ESTIMATED)
- **Last updated:** 2022-08-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05230381

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05230381, "Intravenous Tranexamic Acid Reducing Intraoperative Blood Loss in Huge Meningiomas Resection". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT05230381. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*